ACE2 protein expression within isogenic cell lines is heterogeneous and associated with distinct transcriptomes.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
05 08 2021
Historique:
received: 26 03 2021
accepted: 16 07 2021
entrez: 6 8 2021
pubmed: 7 8 2021
medline: 21 8 2021
Statut: epublish

Résumé

The membrane protein angiotensin-converting enzyme 2 (ACE2) is a physiologic regulator of the renin-angiotensin system and the cellular receptor for the SARS-CoV-2 virus. Prior studies of ACE2 expression have primarily focused on mRNA abundance, with investigation at the protein level limited by uncertain specificity of commercial ACE2 antibodies. Here, we report our development of a sensitive and specific flow cytometry-based assay for cellular ACE2 protein abundance. Application of this approach to multiple cell lines revealed an unexpected degree of cellular heterogeneity, with detectable ACE2 protein in only a subset of cells in each isogenic population. This heterogeneity was mediated at the mRNA level by transcripts predominantly initiated from the ACE2 proximal promoter. ACE2 expression was heritable but not fixed over multiple generations of daughter cells, with gradual drift toward the original heterogeneous background. RNA-seq profiling identified distinct transcriptomes of ACE2-expressing relative cells to non-expressing cells, with enrichment in functionally related genes and transcription factor target sets. Our findings provide a validated approach for the specific detection of ACE2 protein at the surface of single cells, support an epigenetic mechanism of ACE2 gene regulation, and identify specific pathways associated with ACE2 expression in HuH7 cells.

Identifiants

pubmed: 34354120
doi: 10.1038/s41598-021-95308-9
pii: 10.1038/s41598-021-95308-9
pmc: PMC8342525
doi:

Substances chimiques

RNA, Messenger 0
Receptors, Virus 0
ACE2 protein, human EC 3.4.17.23
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15900

Subventions

Organisme : NHLBI NIH HHS
ID : K08 HL148552
Pays : United States
Organisme : National Heart, Lung, and Blood Institute,United States
ID : K08-HL148552

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2021. The Author(s).

Références

J Gen Virol. 2006 Jun;87(Pt 6):1691-1695
pubmed: 16690935
Nature. 2012 Mar 28;483(7391):531-3
pubmed: 22460880
BMC Cell Biol. 2014 Feb 14;15:6
pubmed: 24528853
Mol Cell Proteomics. 2008 Oct;7(10):2019-27
pubmed: 18669619
Stem Cells. 2001;19(2):125-33
pubmed: 11239167
Am J Med Genet A. 2005 Jul 1;136(1):52-7
pubmed: 15937940
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
PLoS One. 2012;7(4):e35876
pubmed: 22558251
Intensive Care Med Exp. 2015 Dec;3(1):44
pubmed: 26215809
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Nat Med. 2021 Mar;27(3):546-559
pubmed: 33654293
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
FEBS Lett. 2002 Dec 4;532(1-2):107-10
pubmed: 12459472
Front Mol Biosci. 2020 Oct 16;7:568954
pubmed: 33195414
Biotechniques. 2010 Mar;48(3):197-209
pubmed: 20359301
Genome. 2021 Apr;64(4):386-399
pubmed: 33086021
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Biochim Biophys Acta. 2013 Nov;1829(11):1225-35
pubmed: 24100303
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nucleic Acids Res. 2014 Aug;42(14):8845-60
pubmed: 25053837
EBioMedicine. 2020 Oct;60:102976
pubmed: 32971472
Crit Care Med. 2013 Nov;41(11):e334-43
pubmed: 23949470
Cell. 2020 May 28;181(5):1016-1035.e19
pubmed: 32413319
PLoS Genet. 2021 Jan 29;17(1):e1009285
pubmed: 33513160
Elife. 2020 Nov 09;9:
pubmed: 33164751
Nat Methods. 2010 Dec;7(12):1009-15
pubmed: 21057496
Development. 2002 Oct;129(19):4371-86
pubmed: 12223397
Nat Genet. 2020 Dec;52(12):1294-1302
pubmed: 33077915
Mol Cell Endocrinol. 2016 Feb 15;422:1-8
pubmed: 26562171
Epigenetics. 2021 Mar;16(3):263-270
pubmed: 32686577
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
Trends Endocrinol Metab. 2004 May-Jun;15(4):166-9
pubmed: 15109615
Circ Res. 2016 Apr 15;118(8):1313-26
pubmed: 27081112
Nucleic Acids Res. 2019 Jan 8;47(D1):D100-D105
pubmed: 30445619
J Virol. 2010 Dec;84(24):12658-64
pubmed: 20926566
Am J Physiol Lung Cell Mol Physiol. 2020 Jun 1;318(6):L1280-L1281
pubmed: 32432918
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Cell. 2015 Dec 17;163(7):1663-77
pubmed: 26627738
Nature. 2005 Jul 7;436(7047):112-6
pubmed: 16001071
J Transl Med. 2019 Jun 4;17(1):188
pubmed: 31164135
Bioinformatics. 2009 May 1;25(9):1105-11
pubmed: 19289445
J Cell Mol Med. 2020 Aug;24(16):9478-9482
pubmed: 32639084
Mol Syst Biol. 2020 Jul;16(7):e9610
pubmed: 32715618
Kidney Int. 2020 Dec;98(6):1502-1518
pubmed: 33038424
Clin Infect Dis. 2020 Jul 28;71(15):870-874
pubmed: 32215613
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nat Genet. 2020 Dec;52(12):1283-1293
pubmed: 33077916
Trends Endocrinol Metab. 2020 Dec;31(12):918-927
pubmed: 33082024
J Surg Res. 2013 Dec;185(2):740-7
pubmed: 23890397
Neuron. 2007 Aug 2;55(3):417-33
pubmed: 17678855
Nature. 2015 Feb 5;518(7537):27-9
pubmed: 25652980
Biochem Biophys Res Commun. 2020 Feb 17;:
pubmed: 32081428
Front Med. 2020 Apr;14(2):185-192
pubmed: 32170560
EMBO J. 2011 Sep 06;30(21):4489-99
pubmed: 21897365
Nat Biotechnol. 2020 Aug;38(8):970-979
pubmed: 32591762
J Biol Chem. 2000 Oct 27;275(43):33238-43
pubmed: 10924499
J Med Virol. 2020 Jul;92(7):726-730
pubmed: 32221983
Am J Physiol Endocrinol Metab. 2015 Jun 15;308(12):E1066-75
pubmed: 26078188
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
J Virol. 2011 Dec;85(24):13363-72
pubmed: 21994442
PLoS One. 2020 Oct 28;15(10):e0240647
pubmed: 33112891
J Mol Med (Berl). 2012 Jun;90(6):637-47
pubmed: 22246130
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758

Auteurs

Emily J Sherman (EJ)

Department of Internal Medicine, Division of Hospital Medicine, University of Michigan, Ann Arbor, MI, USA.

Brian T Emmer (BT)

Department of Internal Medicine, Division of Hospital Medicine, University of Michigan, Ann Arbor, MI, USA. bemmer@med.umich.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH